Sandy A. Liebhard

Mar 07, 2019

Bernstein Liebhard LLP Launches Uloric Lawsuit Investigation, After FDA Concludes Febuxostat Increases Risk for Heart-Related Death and Death from All Causes Compared to Alternative Gout Medication

Jan 11, 2019

Bernstein Liebhard LLP Evaluating Potential Valsartan Lawsuits for Cancer and Liver Injuries Allegedly Caused by Contaminated Heart and Blood Pressure Medications

Sep 20, 2018

Bernstein Liebhard LLP Partner Named to Plaintiffs' Executive Committee for Federal Onglyza Heart Failure Lawsuits

Mar 28, 2018

Tasigna Lawsuits Mount, as Plaintiff in Washington State Accuses Novartis of Failing to Warn that Leukemia Drug Had Been Linked to Atherosclerosis-Related Conditions, Bernstein Liebhard LLP Reports

Dec 21, 2017

Federal Judicial Panel to Address Onglyza Lawsuit Consolidation at January 25th Hearing, Bernstein Liebhard LLP Reports

Oct 25, 2017

Appeals Court Upholds $27 Million Judgment in Boston Scientific Transvaginal Mesh Lawsuits, Bernstein Liebhard LLP Reports

Oct 04, 2017

U.S. Supreme Court Turns Back Appeal of $3.27 Million Ethicon Transvaginal Mesh Lawsuit Verdict, Bernstein Liebhard LLP Reports

Jun 05, 2017

Stryker Hip Recall News: New Jersey Supreme Court Centralizes Product Liability Lawsuits Involving L-FIT V40 Femoral Heads in Bergen County Superior Court, Bernstein Liebhard LLP Reports